This indicates that expression of Cav-1 in the in-vitro RCC cells was not maintained through enhanced NF-kappaB signalling, and that the functional properties of Cav-1 in the in-vitro assays were not downstream of RANKL-dependent pathways. Here, CAV1 is linked to renal cell carcinoma.